secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senseonics Holdings, Inc. (SENS)
CIK:        0001616543
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0001104659-24-060535
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senseonics Q1 revenue up 22% to $5.1M; net loss $18.9M vs income $1.3M
----------------------------------------------------------------------

- Revenue $5.1M (+22% YoY); U.S. $3.7M (+76%), OUS $1.4M (-30%).
- Net loss $18.9M ($0.03 diluted loss) vs net income $1.3M in Q1 2023, driven by non-cash derivative accounting.
- First half 2024 revenue outlook unchanged at $10M (~16% growth YoY).
- Received iCGM designation for Eversense; FDA 510(k) filed for 365-day system.
- Collaboration with Mercy health system to manage 30,000 potential CGM users.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1616543/000110465924060535/0001104659-24-060535-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1616543/000110465924060535/tm2414203d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-060535

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer